Inogen (INGN) Cash from Operations Growth (5y) (2018 - 2026)
Inogen (INGN) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.52 Bn | 176.22 Bn | 6.27 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.61 Bn | 99.39 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.35 Bn | 66.90 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.86 Bn | 1.29 Bn |
| 6 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.92 Bn | 26.35 Bn | - |
| 9 | Koninklijke Philips | 25.49 Bn | 22.36 Bn | 2.07 Bn |
| 10 | Inogen | 175.41 Mn | 65.24 Mn | 37.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -34.11% |
| Dec 31, 2025 | -15.53% |
| Sep 30, 2025 | -20.32% |
| Jun 30, 2025 | -20.30% |
| Mar 31, 2025 | -101.35% |
| Dec 31, 2024 | -18.35% |
| Sep 30, 2024 | -13.69% |
| Jun 30, 2024 | -18.35% |
| Mar 31, 2024 | -21.09% |
| Dec 31, 2023 | -17.66% |
| Sep 30, 2023 | -31.39% |
| Jun 30, 2023 | -28.13% |
| Mar 31, 2023 | -20.25% |
| Dec 31, 2022 | -26.11% |
| Sep 30, 2022 | -20.55% |
| Jun 30, 2022 | -20.02% |
| Mar 31, 2022 | -27.50% |
| Dec 31, 2021 | 4.63% |
| Sep 30, 2021 | -18.44% |
| Jun 30, 2021 | 7.52% |